Dr Tomohide Takaya is studying on muscle stem cells (myoblasts) and bone precursor cells (osteoblasts) that are key players during progression of muscle atrophy, cancer cachexia, and osteoporosis in old peaple and chronic disease patients. He identified a series of single-strand short oligodeoxynucleotides (ODNs), named myoDN and osteoDN, which promote myogenic and osteogenic differentiation. His lablatory is trying to apply these ODNs as nucleic acid drugs for musculoskeletal disorders.
Dr Tomohide Takaya is studying on muscle stem cells (myoblasts) and bone precursor cells (osteoblasts) that are key players during progression of muscle atrophy, cancer cachexia, and osteoporosis in old peaple and chronic disease patients. He identified a series of single-strand short oligodeoxynucleotides (ODNs), named myoDN and osteoDN, which promote myogenic and osteogenic differentiation. His lablatory is trying to apply these ODNs as nucleic acid drugs for musculoskeletal disorders.